ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy

F. Lin; M.C. de Gooijer; E.M. Roig; L.C.M. Buil; S.M. Christner; J.H. Beumer; T. Wurdinger; J.H. Beijnen; O. van Tellingen

doi:https://doi.org/10.1158/1078-0432.CCR-14-0084

ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy

F. Lin, M.C. de Gooijer, E.M. Roig, L.C.M. Buil, S.M. Christner, J.H. Beumer, T. Wurdinger, J.H. Beijnen, O. van Tellingen

Neurosurgery (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

105 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2703-2713
Journal	Clinical Cancer Research
Volume	20
Issue number	10
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-0084
Publication status	Published - 2014

Access to Document

https://doi.org/10.1158/1078-0432.CCR-14-0084

Cite this

@article{78920d4d36cc4d408ba06696efc64d0e,

title = "ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy",

author = "F. Lin and {de Gooijer}, M.C. and E.M. Roig and L.C.M. Buil and S.M. Christner and J.H. Beumer and T. Wurdinger and J.H. Beijnen and {van Tellingen}, O.",

year = "2014",

doi = "https://doi.org/10.1158/1078-0432.CCR-14-0084",

language = "Undefined/Unknown",

volume = "20",

pages = "2703--2713",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy

AU - Lin, F.

AU - de Gooijer, M.C.

AU - Roig, E.M.

AU - Buil, L.C.M.

AU - Christner, S.M.

AU - Beumer, J.H.

AU - Wurdinger, T.

AU - Beijnen, J.H.

AU - van Tellingen, O.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1158/1078-0432.CCR-14-0084

DO - https://doi.org/10.1158/1078-0432.CCR-14-0084

M3 - Article

C2 - 24647572

SN - 1078-0432

VL - 20

SP - 2703

EP - 2713

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -